You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 128 No. 12, December 2002 TABLE OF CONTENTS
  Archives
  •  Online Features
  Original Article
 This Article
 •Full text
 •PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citing articles on ISI (7)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Topic Collections
 •Neoplasms of Head & Neck
 •Salivary Gland Disorders
 •Alert me on articles by topic

Pleomorphic Adenoma of the Submandibular Gland

Clinicopathological and Immunohistochemical Features of 60 Cases in Brazil

Fàbio A. Alves, DDS,PhD; Daniel E. C. Perez, DDS; Osley P. Almeida, DDS,PhD; Márcio A. Lopes, DDS,PhD; Luiz P. Kowalski, MD,PhD

Arch Otolaryngol Head Neck Surg. 2002;128:1400-1403.

The submandibular gland is involved in only 5% to 10% of the salivary gland tumors, and pleomorphic adenoma (PA) is the most common tumor affecting it. This study describes the clinicopathological features and immunohistochemical expression of Ki-67 and p53 in 60 cases of submandibular salivary gland PAs. Most of the patients were in the third and fifth decades of life and 37 (62%) of them were women. Tumor sizes varied from 1 to 10 cm and the mean time between symptom onset and treatment was 52 months. Only 1 patient experienced local recurrence, 3 years after treatment. Histologically, most tumors consisted chiefly in a chondromyxoid stroma. Stroma-rich PAs were larger than stroma-poor ones (P<.02). All PAs were found negative for Ki-67 and p53. These results show that PAs of the submandibular gland are histologically similar to PAs of other salivary glands, and that they have a low proliferative rate and a good prognosis.


From the Departments of Oral Pathology and Semiology, School of Dentistry of Piracicaba, University of Campinas-UNICAMP (Drs Alves, Perez, Almeida, and Lopes), and Head and Neck Surgery and Otorhinolaryngology, Cancer Hospital AC Camargo (Dr Kowalski), São Paulo, Brazil.







HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2002 American Medical Association. All Rights Reserved.